← Eichor
Study identifier: NCT07730515 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

Condition: Non-hodgkin Lymphoma · Peripheral T-cell Lymphoma  ·  Sponsor: Evopoint Biosciences Inc.

PhasePhase 1/Phase 2
Planned participants176
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

In this study, the XNW5004 tablets combined with CHOP/CHOEP will be used for the treatment of newly diagnosed PTCL patients.

This description comes directly from the study's public registry record.

Talk to the study team

Linlin.li Li  ·  18678888561  ·  linlin.li@evopointbio.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Cancer CenterShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07730515